FDA Adverse Event Injury Summary report: N

OT ULTRA2 METER

MDR report key: 2922853 · Received January 18, 2013

Report

Report Number
3008382007-2013-01076
Event Type
Injury
Date Received
January 18, 2013
Date of Event
January 9, 2013
Report Date
January 10, 2013
Manufacturer
LIFESCAN EUROPE, A DIVISION OF CILAG GMBH INTL
Product Code
NBW
PMA / PMN Number
K053529
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
PATIENT

Narratives

Description of Event or Problem · 1

ON (B)(6) 2013 THE LAY USER/PATIENT CONTACTED LIFESCAN (LFS) ALLEGING HER ONETOUCH ULTRA2 METER WAS DISPLAYING INACCURATE RESULTS WHEN COMPARED TO THE SAME METER. THE COMPLAINT WAS CLASSIFIED BASED ON THE CUSTOMER CARE ADVOCATE (CCA) DOCUMENTATION. THE PATIENT REPORTED ON (B)(6) 2013 AT 11PM, SHE OBTAINED READINGS OF '500, 269, 132, 333 AND 129MG/DL' ON THE LFS METER. THE PATIENT REPORTED TAKING NO MEDICATIONS TO MANAGE HER DIABETES. IT IS UNCLEAR IF THE PATIENT MADE ANY CHANGES TO HER USUAL DIET, ACTIVITY LEVEL OR MEDICATIONS ON THE DAY OF THE ALLEGED ISSUE. THE PATIENT REPORTED 10-15 MINUTES AFTER THE ISSUE OCCURRED, SHE DEVELOPED SYMPTOMS OF 'FEELS PALE, NAUSEA, SHAKY, SWEATY AND DIZZY.' THE PATIENT REPORTED ON (B)(6) 2013 BETWEEN 11:30-12:15PM, SHE HAD SOMETHING TO EAT OR DRINK IN RESPONSE TO HER SYMPTOMS. AT THE TIME OF TROUBLESHOOTING, THE CCA NOTED THE PATIENT WAS USING AN APPROVED SAMPLE SITE FOR TESTING. THE PATIENT WAS FOUND TO BE USING THE CORRECT TESTING STEPS AND HIS TEST STRIPS AND TEST STRIPS VIAL WERE IN GOOD CONDITION. WHEN A CONTROL SOLUTION WAS RUN, THE RESULT WAS WITHIN THE RECOMMENDED RANGE. REPLACEMENT PRODUCTS WERE SENT TO THE PATIENT. THIS COMPLAINT IS BEING REPORTED AS AN ADVERSE EVENT BECAUSE THE PATIENT CLAIMS DUE TO THE ALLEGED ISSUE SHE DEVELOPED SYMPTOMS SUGGESTIVE OF HYPOGLYCEMIA AND REQUIRED SELF TREATMENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
28008 OT ULTRA2 METER GLUCOSE MONITORING SYS/KIT NBW LIFESCAN EUROPE, A DIVISION OF CILAG GMBH INTL 3366889

Patients

Seq Age Sex Outcome Treatment
1 72 YR Life Threatening| R